National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-HER3 monoclonal antibody U3-1287
A fully human monoclonal antibody directed against the membrane-bound receptor HER3 (ERBB3) with potential antineoplastic activity. Anti-HER3 monoclonal antibody U3-1287 binds to and inhibits HER3 activation, which may result in inhibition of HER3-dependent PI3K/Akt signaling and so inhibition of cellular proliferation and differentiation. HER3, a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases, is frequently overexpressed in solid tumors, including breast, lung, and colorectal tumors of epithelial origin; it has no active kinase domain itself but is activated through heterodimerization with other members of the EGFR receptor family that do. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code names:AMG 888
U3-1287



Previous:anti-EpCAM antibody fragment-bouganin fusion protein, anti-EpCAM/anti-CD3 recombinant bispecific monoclonal antibody MT110, anti-ErbB3 receptor monoclonal antibody MM-121, anti-FLT-1 ribozyme, anti-GP-3 monoclonal antibody
Next:anti-HGF monoclonal antibody SCH900105, anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968, anti-human chorionic gonadotropin vaccine, anti-IGF-1 receptor human monoclonal antibody R1507, anti-IGF-1R fully human monoclonal antibody AMG-479

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov